SymBio Pharmaceuticals Limited
シンバイオ製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4582
FY2025 · 2025-12-31
| Gross margin | 72.4% |
| Operating margin | -339.6% |
| Net margin | -365.3% |
| Return on equity | -524.1% |
| Return on assets | -123.5% |
| Revenue growth (YoY) | -46.7% |
| EPS (basic) | ¥-95.12 |
| EPS growth (YoY) | — |
| Current ratio | 2.96x |
| Equity ratio | 23.6% |
| Book value / share | ¥15.54 |
| Free cash flow | — |